AmirI, HermeshH, GavishA. Bruxism secondary to antipsychotic drug exposure: A positive response to propranolol. Clin Neuropharmacol, 20:86–89. 1997.
2.
BarnoyEL, NajdowskiAC, TarboxJ, WilkeAE, NolletMD. Evaluation of a multicomponent intervention for diurnal bruxism in a young child with autism. J Appl Behav Anal, 42:845–848. 2009.
3.
BebkoJM, LennoxC. Teaching the control of diurnal bruxism to two children with autism using a simple cueing procedure. Behav Ther, 19:249–255. 1988.
4.
BostwickJM, JaffeeMS. Buspirone as an antidote to SSRI-induced bruxism in 4 cases. J Clin Psychiatry, 60:857–860. 1999.
5.
Bristol-Myers Squibb Co. Buspirone Product Monograph. www.packageinserts.bms.com/pi/pi_Buspirone.pdf. 2010 October 6.
6.
CocchiR, LammaA. Internal stress and bruxism: An investigation on children and young adults with or without Down's syndrome, with autism or other pervasive developmental disorders. Ital J Intellect Impair, 12:13–16. 1999.
7.
DeMatteiR, CuvoA, MaurizioS. Oral assessment of children with an autism spectrum disorder. J Dent Hyg, 81:1–11. 2007.
8.
EllisonJM, StanzianiP. SSRI-associated nocturnal bruxism in four patients. J Clin Psychiatry, 54:432–434. 1993.
9.
GlarosAG, RaoSM. Bruxism: A critical review. Psychol Bull, 84:767–781. 1977.
10.
GuyW. Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: U.S. Department of Health, Education, and Welfare, National Institute of Mental Health, 1976; 218–222.
11.
KingBH, HollanderE, SikichL, McCrackenJT, ScahillL, BregmanJD, DonnellyCL, AnagnostouE, DukesK, SullivanL, HirtzD, WagnerA, RitzL. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Arch Gen Psychiatry, 66:583–590. 2009.
12.
LangR, WhitePJ, MachalicekW, RispoliM, KangS, AquilarJ, O'ReillyM, SigafoosJ, LancioniG, DiddenR. Treatment of bruxism in individuals with developmental disabilities: A systematic review. Res Dev Disabil, 30:809–818. 2009.
13.
LavigneGJ, SoucyJ-P, LobbezooF, ManziniC, BlanchetPJ, MontplaisirJY. Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism. Clin Neuropharmacol, 24:145–159. 2001.
14.
MonroyPG, da FonsecaMA. The use of botulinum toxin-A in the treatment of severe bruxism in a patient with autism: A case report. Spec Care Dentist, 26:37–39. 2006.
15.
MuthuMS, PrathibhaKM. Management of a child with autism and severe bruxism: A case report. J Indian Soc Pedod Prev Dent, 26:82–84. 2008.
16.
OhmureH, OikawaK, KanematsuK, SaitoY, YamamotoT, NaghamaH, TsubouchiH, MiyawakiS. Influence of experimental esophageal acidification on sleep bruxism: A randomized trial. J Dent Res, 90:665–671. 2011.
17.
RanjanS, ChandraPS, PrabhuS. Antidepressant-induced bruxism: Need for buspirone?Int J Neuropsychopharmacol, 9:485–487. 2006.
